FIELD: medicine.
SUBSTANCE: application 2-ethyl-6-methyl-3-oxpyridine succinate (Mexicor) as agent for accelerated physical rehabilitation of patients suffering from myocardium heart attack is offered. Agent application allows to accelerate physical rehabilitation of patients, to raise tolerance (to adapt muscles), and to restore vascular endothelium reaction to physical activity for patients suffering from myocardium heart attack.
EFFECT: medicinal agent has improved efficiency.
2 tbl
Title | Year | Author | Number |
---|---|---|---|
USE OF MEXICOR FOR FASTER PHYSICAL REHABILITATION OF PATIENTS WITH CHRONIC CARDIAC FAILURE | 2006 |
|
RU2325157C2 |
METHOD FOR TREATMENT OF ACUTE MYOCARDIAL INFARCTION | 2005 |
|
RU2299730C1 |
USING PREPARATION 2-ETHYL-6-METHYL-3-OXYPYRIDINE IN CARRYING OUT TOTAL ANESTHESIA AND IN POST-NARCOSIS PERIOD FOR REDUCING RISK OF COMPLICATIONS DEVELOPMENT | 2004 |
|
RU2290180C2 |
METHOD FOR REHABILITATION IN PATIENTS WITH MYOCARDIAL INFARCTION | 2003 |
|
RU2254846C2 |
METHOD OF TREATING CARDIOVASCULAR PATIENTS AFTER SUFFERING ACUTE CORONARY SYNDROME AND CARDIOSURGICAL INTERVENTIONS | 2019 |
|
RU2715209C1 |
AGENT FOR TREATMENT OF PATIENTS WITH NONSTABLE STENOCARDIA AND ACUTE MYOCARDIAL INFARCTION | 2000 |
|
RU2168993C1 |
METHOD OF REHABILITATION OF PATIENTS WITH HISTORY OF MYOCARDIAL INFARCTION AND DISTURBED RHYTHM AND CONDUCTION | 1997 |
|
RU2140300C1 |
METHOD FOR REHABILITATION OF ELDERLY PATIENTS WITH ISCHEMIC HEART DISEASES ACCOMPANIED BY CHRONIC HEART INSUFFICIENCY FOLLOWING MYOCARDIAL INFARCTION | 2014 |
|
RU2554756C1 |
METHOD FOR IMMUNE CORRECTION IN PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION | 2011 |
|
RU2463050C1 |
METHOD FOR REHABILITATION IN PATIENTS AFTER MYOCARDIAL INFARCTION | 2002 |
|
RU2207166C1 |
Authors
Dates
2008-07-10—Published
2006-04-11—Filed